Objective: The aim of this paper is to explore the longitudinal relationships between physical and psychological symptoms and immunological factors following acute infective illnesses.
Method: Preliminary data from a prospective investigation of patients with serologically proven acute infectious illnesses due to Epstein-Barr virus (EBV), Ross River virus (RRV) or Q fever are reported. Patients were assessed within 4 weeks of onset of symptoms and then reviewed 2 and 4 weeks later. Physical illness data were collected at interview. Psychological and somatic symptom profiles were assessed by standardised self-report questionnaires. Cell-mediated immune (CMI) function was assessed by measurement of delayed-type hypersensitivity (DTH) skin responses.
Results: Thirty patients who had been assessed and followed over the 4–week period (including 17 patients with EBV, five with RRV and eight with Q fever) were included in this analysis. During the acute phase, profound fatigue and malaise were the most common symptoms. Classical depressive and anxiety symptoms were not prominent. Initially, 46% of cases had no DTH skin response (i.e. cutaneous anergy) indicative of impaired cellular immunity. Over the 4–week period, there was a marked improvement in both somatic and psychological symptoms, although fatigue remained a prominent feature in 63% of subjects. The reduction in reported fatigue was correlated with improvement in the DTH skin response (p = 0.001) and with improvement in General Health Questionnaire (GHQ) scores (p < 0.01).
Conclusions: Acute infectious illnesses are accompanied by a range of nonspecific somatic and psychological symptoms, particularly fatigue and malaise rather than anxiety and depression. Although improvement in several symptoms occurs rapidly, fatigue commonly remains a prominent complaint at 4 weeks. Resolution of fatigue is associated with improvement in cell-mediated immunity.
SmithATyrrellDCoyleKHigginsP.Effects of interferon alpha on performance in man: a preliminary report. Psychopharmacology1988; 96:414–416.
8.
KruegerJMWalterJDinarelloCAWolffSMChedidL.Sleep-promoting effects of endogenous pyrogen (interleukin-1). American Journal of Physiology1984; 246:R994–R999.
9.
SmedleyHKatrakMSikoraKWheelerT.Neurological effects of recombinant human interferon. British Medical Journal1983; 286:262–264.
10.
SmithAPTyrrellDAJAl-NakibWThe effects of experimentally induced respiratory virus infections on performance. Psychological Medicine1988; 18:65–71.
11.
Vollmer-ConnaUWakefieldDLloydACognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression. British Journal of Psychiatry1997; 171:377–381.
12.
SchooleyRTEpstein-Barr virus (infectious mononucleosis) In: MandellGLDouglasRGBennettJE, eds. Principles and practice of infectious diseases. 3rd ed.New York: Churchill Livingstone, 1995:1364–1377.
13.
WhitePDThomasJMAmessJGroverSAKangroHOClareAWThe existence of a fatigue syndrome after glandular fever. Psychological Medicine1995; 25:907–916.
14.
WhitePDGroverSAKangroHOThomasJMAmessJClareAWThe validity and reliability of the fatigue syndrome that follows glandular fever. Psychological Medicine1995; 25:917–924.
15.
FraserJREEpidemic polyarthritis and Ross River virus disease. Clinics in Rheumatic Diseases1986; 12:369–388.
16.
CurranMHarveyBCrerarSAustralia's notifiable diseases status 1996. Communicable Diseases Intelligence1997; 21:281–307.
17.
SeldonSMCameronASChanging epidemiology of Ross River virus disease in South Australia. Medical Journal of Australia1996; 165:313–317.
18.
National Centre for Diseases Unit, Department of Health and Family Services.Communicable diseases surveillance. Communicable Diseases Intelligence1997; 21:323–331.
19.
MarmionBOPShannonMMaddocksIStormPPenttilaI.Protracted debility and fatigue after acute Q fever [letter]. Lancet1996; 347:977–978.
20.
HickieILloydAWakefieldDRicciC.Is there a postinfection fatigue syndrome?Australian Family Physician1996; 1847–1852.
21.
Composite International Diagnostic Interview.CIDI-Auto version 1.1 [computer program]. Sydney: WHO CIDI Training and Reference Centre, 1993.
22.
HickieILloydAHadzi-PavlovicDParkerGBirdKWakefieldD.Can the chronic fatigue syndrome be defined by distinct clinical features?Psychological Medicine1995; 25:925–935.
23.
HickieIBHookerAWHadzi-PavlovicDBennettBKWilsonAWLloydARFatigue in selected primary care settings: sociodemographic and psychiatric correlates. Medical Journal of Australia1996; 164:585–588.
24.
McNairDMLorrMDropplemanLEManual for the Profile of Mood States. San Diego: San Diego Educational and Industrial Testing Service, 1971.
25.
GoldbergDWilliamsP.A user's guide to the General Health Questionnaire. Berkshire: NFER-Nelson Publishing, 1988.
26.
KnikerWTAndersonCTRoumiantzeffM.The multi-test system: a standardized approach to evaluation of delayed hyper-sensitivity and cell-mediated immunity. Annals of Allergy1979; 43:73–79.
27.
KnikerWTAndersonCTMcBrydeJLRoumiantzeffMLesourdB.Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the USA. Annals of Anergy1984; 52:75–81.
28.
LloydAHickieIHickieCWakefieldD.Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clinical and Experimental Immunology1992; 87:76–79.
29.
HickieIHickieCLloydASiloveDWakefieldD.Impaired in vivo immune responses in patients with melancholia. British Journal of Psychiatry1993; 162:651–657.
30.
HickieIHickieCSiloveDWakefieldDLloydA.Delayed type hypersensitivity skin testing: normal values in an Australian population. International Journal of Immunopharmacology1995; 17(Suppl.):629–634.
31.
HaiderSde CoutinhoM LEmondRTDTuberculin anergy and infectious mononucleosis. Lancet1973; 2:74.
32.
FukudaKStrausSEHickieISharpeMCDobbinsJGKomaroff A, and the International Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine1994; 121:953–959.
33.
HickieILloydARWakefieldD.Chronic fatigue syndrome: current perspectives on evaluation and management. Medical Journal of Australia1995, 163:314–318.